EPISODE · Aug 13, 2026 · 5 MIN
FDA Approval Won't Make Stem Cell Therapy Cheaper | #195
from The Dr. Joy Kong Podcast · host Dr. Joy Kong
If you're holding off on stem cell therapy because you're waiting for FDA approval to bring the price down, this is the reality check you need.Dr. Joy Kong, a triple board certified physician and stem cell specialist at Chara Health, breaks down what FDA approved stem cell products actually cost. Cord blood transplants like Omidacel and AlloCord run $450,000 to $1.2 million. Ryoncil, used for pediatric graft versus host disease, totals $1.55 million. By comparison, current stem cell therapy provided as a legal tissue transplant, the same model used in organ transplants, costs $7,000 to $25,000 per infusion.Dr. Joy explains why that gap exists, and what it means if you're counting on insurance to make this treatment affordable.✨ Learn more about how to live a long and pain-free life: https://joykongmd.com/Dr. Joy talks about:0:21 Why FDA Approval Doesn't Lower Cost2:26 Cost Of FDA-Approved Stem Cell Products3:40 Why Legal Stem Cell Therapy Is CheaperAdditional ResourcesVisit My Clinic: Chara Health🌐 https://chara-health.com📍 9568 Topanga Canyon Blvd. Los Angeles, CA 91311📲 Call (818) 356-8232 or email [email protected] to make an appointment or go to https://www.joykongmd.com and fill out a contact form.✨ Follow me on Facebook: https://www.facebook.com/stemcelldrjoy/✨ Follow me on Instagram: https://www.instagram.com/dr_joy_kong/About Dr. Joy KongDr. Joy Kong is a regenerative medicine and anti-aging expert. Her podcast is part of her mission to reduce suffering and elevate happiness. Join us every week for the latest holistic health insights that will help you live a long and pain-free life.
Embed this episode
NOW PLAYING
FDA Approval Won't Make Stem Cell Therapy Cheaper | #195
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.